Views & Analysis Comms from the ground up David Hunt’s career has taken him from painting Havas Lynx Group’s offices to running the agency, and now to LA to head up the West Coast for Havas Health & You.
News Roche taps Simcere for autoimmune trispecific for $1.53bn Roche is paying $75m upfront for a trispecific drug developed by China's Simcere Zaiming for B-cell-mediated autoimmune disorders and blood cancers.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.